Area of research
Hepatology · Surgery
Research interest
Research interests include Liver Disease and Transplantation, Organ Transplantation Techniques and Outcomes, Liver Disease Diagnosis and Treatment, and Renal Transplantation Outcomes and Treatments.
Waitlist mortality in liver transplantation: Understanding metrics, regulatory implications, and clinical management strategies
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting
Future of U.S. living donor liver transplant: Donor and recipient criteria, transplant indications, transplant oncology, liver paired exchange, and non-directed donor graft allocation
Excess waitlist mortality among candidates for multivisceral liver-intestine transplant in acuity circle allocation
Implementation of a National Liver Review Board for exception requests in the United States: A 2-year monitoring report
Iatrogenic hypervitaminosis A: An underrecognized complication in the liver transplant recipient
Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis
Prognosis of hospitalized patients with cirrhosis and acute kidney disease
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension
Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis
Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax
Progression of Stage 2 and 3 Acute Kidney Injury in Patients With Decompensated Cirrhosis and Ascites
Solid organ donation after death in the United States: Data-driven messaging to encourage potential donors.
Impact of Chronic Kidney Disease on Outcomes in Cirrhosis
Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis
Outcomes After Listing for Liver Transplant in Patients With Acute‐on‐Chronic Liver Failure: The Multicenter North American Consortium for the Study of End‐Stage Liver Disease Experience
Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis
NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis
Neutrophil-to-Lymphocyte Ratio Associates Independently With Mortality in Hospitalized Patients With Cirrhosis
The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis
Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort
Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes
Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures
A Karnofsky performance status–based score predicts death after hospital discharge in patients with cirrhosis
Changing prioritization for transplantation
Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience
The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis
Donor-Derived Transmission Events in 2013
Low, rather than high, body mass index confers increased risk for post‐liver transplant death and graft loss: Risk modulated by model for end‐stage liver disease